Free tool
FAERS Monitor: Vandazole
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 021806 or its brand name (Vandazole, Metronidazole). Reports on generic versions are filed under their own applications.
Reports
48,130
Serious
41,923
87% of reports
Hospitalization
19,848
Death reported
5,412
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- drug ineffective4,663
- nausea3,461
- off label use3,386
- diarrhoea2,713
- vomiting2,329
- pyrexia2,288
- headache2,259
- pain2,123
- abdominal pain2,122
- fatigue1,960
- dizziness1,686
- condition aggravated1,637
- dyspnoea1,598
- acute kidney injury1,543
- malaise1,470
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 459 |
| 2005 | 480 |
| 2006 | 483 |
| 2007 | 512 |
| 2008 | 320 |
| 2009 | 677 |
| 2010 | 859 |
| 2011 | 1,167 |
| 2012 | 1,431 |
| 2013 | 1,112 |
| 2014 | 1,452 |
| 2015 | 2,169 |
| 2016 | 2,477 |
| 2017 | 2,510 |
| 2018 | 4,185 |
| 2019 | 4,493 |
| 2020 | 3,820 |
| 2021 | 3,875 |
| 2022 | 3,401 |
| 2023 | 3,458 |
| 2024 | 3,163 |
| 2025 | 3,437 |
| 2026 | 2,187 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,006,029 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| acute kidney injurySignal | 1,543 | 4.4 | 4.2 | 4,099 |
| abdominal painSignal | 2,122 | 4.0 | 3.8 | 4,808 |
| pyrexiaSignal | 2,288 | 2.9 | 2.8 | 2,879 |
| condition aggravatedSignal | 1,637 | 2.4 | 2.3 | 1,294 |
| vomitingSignal | 2,329 | 2.2 | 2.1 | 1,495 |
| nausea | 3,461 | 1.9 | 1.9 | 1,564 |
| diarrhoea | 2,713 | 1.8 | 1.8 | 1,068 |
| off label use | 3,386 | 1.7 | 1.6 | 997 |
| headache | 2,259 | 1.6 | 1.5 | 489 |
| drug ineffective | 4,663 | 1.5 | 1.5 | 961 |
| pain | 2,123 | 1.5 | 1.5 | 377 |
| dizziness | 1,686 | 1.5 | 1.4 | 266 |
| malaise | 1,470 | 1.5 | 1.4 | 221 |
| dyspnoea | 1,598 | 1.2 | 1.2 | 73 |
| fatigue | 1,960 | 1.1 | 1.1 | 18 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.